Traders should monitor shareholder vote outcome and regulatory approvals; arbitrage opportunity exists between current trading price and C$2.41 offer price, with deal completion risk as primary downside
Price Chart
Executive Summary
Aptose Biosciences announced that Institutional Shareholder Services (ISS) recommends shareholders vote in favor of the proposed acquisition by Hanmi Pharmaceutical, offering C$2.41 per share in cash, representing a 28% premium over the 30-day VWAP. A special shareholder meeting is scheduled for March 31, 2026, with a voting deadline of March 27, 2026.
Key Facts
- Hanmi Pharmaceutical to acquire all outstanding common shares of Aptose not already owned for C$2.41 per share in cash
- Offer represents a 28% premium over Aptose's 30-day VWAP of C$1.88 on the TSX
- ISS recommends shareholders vote FOR the arrangement, citing premium valuation, positive market reaction, and certainty of cash proceeds
- Special shareholder meeting reconvened to March 31, 2026, with voting deadline of March 27, 2026
- Transaction subject to customary closing conditions including court and TSX approval
Financial Impact
C$2.41 per share in cash, 28% premium to 30-day VWAP
Risk Factors
- Failure to obtain required shareholder, court, or TSX approvals
- Competing bids could emerge before deal closes
- Potential delay or termination of transaction
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001171843-26-001777 |
| Exhibit: exh_991.htm | 0001171843-26-001777 |
| Document: 0001171843-26-001777-index-headers.html | 0001171843-26-001777 |
| Document: 0001171843-26-001777-index.html | 0001171843-26-001777 |
| Document: 0001171843-26-001777.txt | 0001171843-26-001777 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 1, 2026 16w ago | 15-12G | $1.68 $1.69 | ▼ −0.60% | ▼ −0.64% | — |
Jun 15, 2026 19w ago | 8-K | $1.61 $1.48 | ▼ −8.07% | ▼ −5.46% | — |
May 29, 2026 21w ago | 8-K | $1.65 $1.57 | ▼ −4.85% | ▼ −2.32% | — |
May 13, 2026 23w ago | 8-K | $1.71 $1.71 | · 0.00% | ▲ +0.72% | — |
Mar 19, 2026 31w ago | 8-K | $1.62 $1.64 | ▲ +1.23% | ▲ +3.45% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers